Westview Management Dba Westview Investment Advisors Veracyte, Inc. Transaction History
Westview Management Dba Westview Investment Advisors
- $210 Billion
- Q4 2025
A detailed history of Westview Management Dba Westview Investment Advisors transactions in Veracyte, Inc. stock. As of the latest transaction made, Westview Management Dba Westview Investment Advisors holds 32,690 shares of VCYT stock, worth $1.29 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
32,690Holding current value
$1.29 Million% of portfolio
0.66%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
329Shares Held
78.4MCall Options Held
94.6KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA8.5MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$307 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI7.37MShares$290 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.47MShares$176 Million1.08% of portfolio
-
State Street Corp Boston, MA4.2MShares$165 Million0.01% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.82B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...